NFATc1-IN-1 (also known as compound A04) is a highly effective inhibitor of osteoclast formation induced by RANKL, with an IC50 of 1.57 µM. It exerts its anti-osteoclastogenic effects by attenuating the RANKL-induced nuclear translocation of NFATc1. Due to its remarkable properties, NFATc1-IN-1 holds significant potential for advancing research related to osteoclastic diseases [1].
Molecular Weight:
375.11
Purity:
99.98%
CAS Number:
[1912422-56-0]
Formula:
C13H8F2INO2
Target:
Others|||RANKL/RANK
T61531
* VAT and and shipping costs not included. Errors and price changes excepted
